Mark Bachleda

Insider Reports History

Entity
Individual
Location
C/O Galera Therapeutics, Inc., 2 W Liberty Boulevard, #110, Malvern, Pennsylvania
Signature
/s/ Chris Degnan, Attorney-in-Fact for Mark Bachleda
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Bachleda:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Galera Therapeutics, Inc. Chief Commercial Officer Common Stock 11 K $24.7 K $2.25 Mar 16, 2023 Direct
Galera Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 135 K Feb 25, 2023 Direct

Insider Reports Filed by Mark Bachleda

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRTX Galera Therapeutics, Inc. Mar 16, 2023 1 $24.7 K 4 Mar 20, 2023 Chief Commercial Officer
GRTX Galera Therapeutics, Inc. Feb 25, 2023 1 $0 4 Feb 28, 2023 Chief Commercial Officer
GRTX Galera Therapeutics, Inc. Feb 28, 2022 1 $0 4 Mar 2, 2022 Chief Commercial Officer
GRTX Galera Therapeutics, Inc. Oct 8, 2021 1 $0 4 Oct 12, 2021 Chief Commercial Officer
GRTX Galera Therapeutics, Inc. Oct 8, 2021 0 $0 3 Oct 12, 2021 Chief Commercial Officer